Game-Changer: New Daily Pill Extends Life Expectancy for Advanced Pancreatic Cancer Patients
Image Credit: isn5000/123rf.com At the American Society of Clinical Oncology’s annual meeting in Chicago, groundbreaking results were announced from a clinical trial involving a new drug called daraxonrasib. The trial, which included 500 patients with advanced pancreatic cancer, demonstrated that the drug significantly improved survival rates, doubling the average survival time compared to standard chemotherapy…